夏宁邵 (NingShao Xia)
生命科学学院
ResearcherID:G-4647-2010
2023年当选中国工程院院士。 入选中国医学科学院学部委员、国家杰出青年科学基金、教育部“长江学者奖励计划”特岗学者、国家特支计划科技创新领军人才、全国先进工作者、全国杰出专业技术人才、国家百千万人才工程。以第一完成人获国家技术发明二等奖、国家科技进步二等奖、全国创新争先奖、中国专利金奖、福建省科技重大贡献奖、厦门市科技重大贡献奖、求是杰出科技成就集体奖、转化医学杰出贡献奖。
已发表成果:
WOK 论文 557 篇;中文核心 176 篇;其它论文 55 篇;专利发明 57 个;
Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids
A novel point-of-care test of respiratory syncytial viral RNA based on cellulose-based purification and convective PCR
Early diagnosis and population prevention of coronavirus disease 2019
Molecular characterization of an uncommon multigene Reassortant G1P[4] rotavirus identified in China
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Sequential Acquisition of Human Papillomavirus Infection at Genital and Anal Sites, Liuzhou, China
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
A plasma separator with a multifunctional deformable chamber equipped with a porous membrane for point-of-care diagnostics
Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages
Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks
Expression Level of Small Envelope Protein in Addition to Sequence Divergence inside Its Major Hydrophilic Region Contributes to More Efficient Surface Antigen Secretion by Hepatitis B Virus Subgenotype D2 than Subgenotype A2
Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset
DLL4 restores damaged liver by enhancing hBMSC differentiation into cholangiocytes
Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial
Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development
Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent
Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions
Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
An immunoassay cassette with a handheld reader for HIV urine testing in point-of-care diagnostics
Rapid Neutralization Testing System for Zika Virus Based on an Enzyme-Linked Immunospot Assay
Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo
High-Efficiency Plasma Separator Based on Immunocapture and Filtration
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women
Recent Progress on the Versatility of Virus-Like Particles
Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16
A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice
Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods
Sex Differences in the Incidence and Clearance of Anogenital Human Papillomavirus Infection in Liuzhou, China: An Observational Cohort Study
Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
Animal models for emerging coronavirus: progress and new insights
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
Nucleic Acid Testing for Coronavirus Disease 2019: Demand, Research Progression, and Perspective
Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
Free convective PCR: From principle study to commercial applications-A critical review
Room-temperature-storable PCR mixes for SARS-CoV-2 detection
COVID-19: Progress in diagnostics, therapy and vaccination
大肠杆菌表达系统在基因工程疫苗研发中的应用与策略优化
中国新药杂志,1003-3734,2020-11-15.双价人乳头瘤病毒疫苗(大肠杆菌)的有效性研究:一项随机对照临床试验的中期分析
中国妇产科临床杂志,1672-1861,2020-11-15.疫苗免疫原的研究进展和趋势
中国科学基金,1000-8217,2020-10-25.寨卡病毒衣壳蛋白单克隆抗体的制备及性能评价
中国病原生物学杂志,1673-5234,2020-08-30.细菌糖基化基本元件及其应用研究进展
微生物学报,0001-6209,2020-08-07.质粒转染比例对人乳头瘤病毒16/18型假病毒制备的影响
病毒学报,1000-8721,2020-06-08.抗原检测在戊型肝炎临床诊断中的应用
病毒学报,1000-8721,2020-06-05.新型冠状病毒抗体检测试剂的临床性能评估方案
病毒学报,1000-8721,2020-04-24.人乳头瘤病毒治疗性疫苗的研究进展
病毒学报,1000-8721,2020-02-13.